journal article·2022-11-22

Biomimetic Yolk–Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer

Yuanbo Pan, Yang Zhu, Canxin Xu, Chunshu Pan, Yu Shi, Jianhua Zou, Yanying Li, Xueyin Hu, Bo Zhou, Chenyang Zhao, Qianqian Gao, Jianmin Zhang, Aiguo Wu, Xiaoyuan Chen, Juan Li

ACS Nano· Volume 16· Issue 11
Publisher page

Abstract

Fenton reaction-based chemodynamic therapy (CDT), which applies metal ions to convert less active hydrogen peroxide (H2O2) into more harmful hydroxyl peroxide (·OH) for tumor treatment, has attracted increasing interest recently. However, the CDT is substantially hindered by glutathione (GSH) scavenging effect on ·OH, low intracellular H2O2 level, and low reaction rate, resulting in unsatisfactory efficacy. Here, a cancer cell membrane (CM)-camouflaged Au nanorod core/mesoporous MnO2 shell yolk–shell nanocatalyst embedded with glucose oxidase (GOD) and Dox (denoted as AMGDC) is constructed for synergistic triple-augmented CDT and chemotherapy of tumor under MRI/PAI guidance. Benefiting from the homologous adhesion and immune escaping property of the cancer CM, the nanocatalysts can target tumor and gradually accumulate in tumor site. For triple-augmented CDT, first, the MnO2 shell reacts with intratumoral GSH to generate Mn2+ and glutathione disulfide, which achieves Fenton-like ion delivery and weakening of GSH-mediated scavenging effect, leading to GSH depletion-enhanced CDT. Second, the intratumoral glucose can be oxidized to H2O2 and gluconic acid by GOD, achieving supplementary H2O2-enhanced CDT. Next, the AuNRs absorbing in NIR-II elevate the local tumor temperature upon NIR-II laser irradiation, achieving photothermal-enhanced CDT. Dox is rapidly released for adjuvant chemotherapy due to responsive degradation of MnO2 shell. Moreover, GSH-activated PAI/MRI can be used to monitor CDT process. This study provides a great paradigm for enhancing CDT-mediated antitumor efficacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cixi Institute of Biomedical Engineering, International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Science (CAS) Key Laboratory of Magnetic Materials and Devices, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, CAS, Ningbo 315201, P.R. China

Department of Neurosurgery, Second Affiliated Hospital, School of Medicine and MOE Frontier Science Center for Brain Science & Brain-Machine Integration, Zhejiang University, Hangzhou, Zhejiang 310003, P. R. China

Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore 119074, Singapore

Clinical Research Center for Neurological Diseases of Zhejiang Province, Hangzhou 310009, China

Department of Neurosurgery, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P. R. China

Department of Radiology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo 315010, P. R. China

University of Chinese Academy of Sciences, Beijing 100049, P. R. China

Funding

Ningbo Municipal Bureau of Science and Technology · Youth Innovation Promotion Association of the Chinese Academy of Sciences · National University of Singapore · National Natural Science Foundation of China · Zhejiang Province · MOE Frontier Science Center for Brain Science and Brain-Machine Integration, Zhejiang University

References (47)

Show source-provided references
1. 10.1002/anie.20171202710.1002/anie.201712027 ↗
2. 10.1021/acsnano.9b0896210.1021/acsnano.9b08962 ↗
3. 10.1016/j.apcatb.2010.11.02210.1016/j.apcatb.2010.11.022 ↗
4. 10.1016/j.nantod.2022.10143510.1016/j.nantod.2022.101435 ↗
5. 10.1002/anie.20201715210.1002/anie.202017152 ↗
6. 10.1002/adma.20180591910.1002/adma.201805919 ↗
7. Arrick B. A. · Cancer Res. · 1984 · 44 · 4224
8. 10.1038/nature0773310.1038/nature07733 ↗
9. 10.1038/bjc.1993.48410.1038/bjc.1993.484 ↗
10. 10.1021/acsnano.8b0938710.1021/acsnano.8b09387 ↗
11. 10.1186/s12951-021-01003-210.1186/s12951-021-01003-2 ↗
12. 10.1002/adma.20200689210.1002/adma.202006892 ↗
13. 10.1021/acsnano.5b0617510.1021/acsnano.5b06175 ↗
14. 10.1002/jcb.2468310.1002/jcb.24683 ↗
15. 10.1021/acs.nanolett.5b0449510.1021/acs.nanolett.5b04495 ↗
16. 10.1039/C7TB00422B10.1039/C7TB00422B ↗
17. 10.1021/acsbiomaterials.2c0013810.1021/acsbiomaterials.2c00138 ↗
18. 10.1021/acsnano.1c0853610.1021/acsnano.1c08536 ↗
19. 10.1002/smll.20200151810.1002/smll.202001518 ↗
20. 10.1002/adma.20180832510.1002/adma.201808325 ↗
21. 10.1002/adma.20210398010.1002/adma.202103980 ↗
22. 10.1021/acsami.8b0181810.1021/acsami.8b01818 ↗
23. 10.1021/acs.nanolett.7b0353110.1021/acs.nanolett.7b03531 ↗
24. 10.1021/acsnano.7b0253310.1021/acsnano.7b02533 ↗
25. 10.1021/nn400647210.1021/nn4006472 ↗
26. 10.1021/jacs.7b0781810.1021/jacs.7b07818 ↗
27. 10.1021/acs.nanolett.7b0467510.1021/acs.nanolett.7b04675 ↗
28. 10.1002/adma.20210362710.1002/adma.202103627 ↗
29. 10.1002/adma.20200854010.1002/adma.202008540 ↗
30. 10.1021/jacs.9b1287310.1021/jacs.9b12873 ↗
31. 10.1002/adhm.20200000510.1002/adhm.202000005 ↗
32. 10.1039/C9NR10039C10.1039/C9NR10039C ↗
33. 10.1016/j.apmt.2019.10046410.1016/j.apmt.2019.100464 ↗
34. 10.1038/s41565-019-0392-310.1038/s41565-019-0392-3 ↗
35. 10.1021/acs.nanolett.8b0390510.1021/acs.nanolett.8b03905 ↗
36. 10.1038/s41467-017-01050-010.1038/s41467-017-01050-0 ↗
37. 10.1039/C9NR09137H10.1039/C9NR09137H ↗
38. 10.1016/j.catcom.2010.12.01310.1016/j.catcom.2010.12.013 ↗
39. 10.1021/acsami.0c0838910.1021/acsami.0c08389 ↗
40. 10.1016/j.susc.2012.09.02410.1016/j.susc.2012.09.024 ↗
41. 10.1002/adma.20190040110.1002/adma.201900401 ↗
42. 10.1002/adfm.20180380410.1002/adfm.201803804 ↗
43. 10.1038/nrm223610.1038/nrm2236 ↗
44. 10.1039/C8BM00604K10.1039/C8BM00604K ↗
45. 10.1002/adma.20217029210.1002/adma.202170292 ↗
46. 10.1038/s41467-021-21436-510.1038/s41467-021-21436-5 ↗
47. 10.1021/acsnano.9b0598510.1021/acsnano.9b05985 ↗